VBI Vaccines Overview

VBI Vaccines Research & Development

Research & Development expenses for VBIV.

Quarterly R&D Expenses

$2.57M

↓ 18.41% YoY

As of Mar 31, 2024

Annual R&D Expenses (TTM)

$8.76M

↓ 46.22% YoY

Trailing 12 months ending Mar 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin